Detecting Cancer While It Is Still Small Impacts Survival
the ONA take:
Detecting breast cancers when they are small still impacts survival despite the various effective therapies, a study published in The BMJ has shown.
Because breast cancer survival rates have significantly improved over the last few decades, mostly due to earlier diagnosis and more effective treatment options, traditional prognostic factors such as tumor size and number of positive lymph nodes are thought to no longer affect survival.
Therefore, researchers in the Netherlands sought to compare survival by tumor size and nodal status in patients with breast cancer during 1995 to 2005 with 2006 to 2012.
Researchers analyzed the overall survival data of 173,797 female patients with breast cancer. They found that tumors diagnosed during the 2006 to 2012 period were smaller, less likely to be lymph node positive, and more often low grade.
Patients with diagnoses during that time were also more likely to have undergone breast-conserving therapy, and the use of hormonal therapy, chemotherapy, and drug therapy were increased.
Results showed that relative survival rates and overall survival rates were higher for the 2006 to 2012 cohort for all tumor and nodal stages, particularly in women ages 75 years and older. The study demonstrated that both tumor stage and nodal status had a significant impact on overall survival in patients from both groups.
“Through public health screening and innovations in treatment, we are making steady progress against breast cancer,” the authors write. “A challenge ahead is to help other societies build models of screening and treatment that foster the access and success of the Dutch experience.”
Detecting breast cancers when they are small still impacts survival despite the various effective therapies.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|